Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

CenturyLink Announces Executive Changes

RELATED NEWS
Trade CTL now with 

CenturyLink Inc. (CTL: Quote) announced the voluntary departure of two executives and the related appointment of three executives to key positions within the company.

The company said that Dennis Huber, executive vice president - network services, will depart the company June 1, 2012. He will be replaced by Maxine Moreau, who currently serves as senior vice president - integration and process improvement, and previously has held leadership positions in various areas of the company, such as information technology, operations and network operations.

Stephanie Comfort, executive vice president - corporate strategy and development, will depart the company July 1, 2012. Matt Beal will assume the role of senior vice president - corporate strategy, product development and chief technology officer. Beal currently serves as senior vice president and chief technology officer, product development and strategy.

Tom McEvoy, senior vice president - integration and process improvement, will assume all integration-related responsibilities previously held by Moreau.

Each of the three newly-named executives will report directly to Post.

Register
To receive FREE breaking news email alerts for CenturyLink, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Proctor and Gamble (PG) has sold two of its soap brands to European consumer products giant Unilever (UN). Cincinnati-based P&G says the sale includes the global Camay brand, the Zest brand outside of North America and its Talisman manufacturing plant in Mexico. The plant employs approximately... Dish Network is no longer carrying Fox News in yet another dispute for the television provider. Fox News, which changed the face of cable news with its ardent advocacy of conservative issues, went dark Sunday, replaced on Dish by The Blaze, Glen Beck's new right-leaning channel. Fox Business channel... Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.